A Ten-Year Strategic Forecast: Biosimulation's Emergence as a Mandatory Standard in Biologic and Gene Therapy Development
  The Biosimulation Market Forecast for the coming decade predicts a pivotal transformation of the technology from a supplementary research tool into a fundamental, mandatory component of pharmaceutical R&D, particularly within the fast-growing biologics, cell, and gene therapy (CGT) sectors. Traditional drug development models are inadequate for managing the complexity of these...
0 Yorumlar 0 hisse senetleri 54 Views 0 önizleme